Cargando…

Pyrosequencing analysis for rapid and accurate detection of clarithromycin resistance-associated mutations in Iranian Helicobacter pylori isolates

BACKGROUND: Treatment of Helicobacter pylori (H. pylori) infection has become challenging following the development of primary antibiotic resistance. A primary therapeutic regimen for H. pylori eradication includes clarithromycin; however, the presence of point mutations within the 23S rRNA sequence...

Descripción completa

Detalles Bibliográficos
Autores principales:	Alavifard, Helia, Nabavi-Rad, Ali, Baghaei, Kaveh, Sadeghi, Amir, Yadegar, Abbas, Zali, Mohammad Reza
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2023
Materias:	Research Note
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10324197/ https://www.ncbi.nlm.nih.gov/pubmed/37415212 http://dx.doi.org/10.1186/s13104-023-06420-0

Ejemplares similares

The double-edged sword of probiotic supplementation on gut microbiota structure in Helicobacter pylori management
por: Nabavi-Rad, Ali, et al.
Publicado: (2022)

The interplay between Helicobacter pylori and the gut microbiota: An emerging driver influencing the immune system homeostasis and gastric carcinogenesis
por: Fakharian, Farzaneh, et al.
Publicado: (2022)

The Effects of Vitamins and Micronutrients on Helicobacter pylori Pathogenicity, Survival, and Eradication: A Crosstalk between Micronutrients and Immune System
por: Nabavi-Rad, Ali, et al.
Publicado: (2022)

Assessment of Helicobacter pylori positive infected patients according to Clarithromycin resistant 23S rRNA, rpl22 associated mutations and cyp2c19*1, *2, *3 genes pattern in the Early stage of Gastritis
por: Maghami, Atena Abedi, et al.
Publicado: (2022)

Helicobacter pylori infection contributes to the expression of Alzheimer's disease-associated risk factors and neuroinflammation
por: Noori, Maryam, et al.
Publicado: (2023)

Combination of pioglitazone and dendritic cell to optimize efficacy of immune cell therapy in CT26 tumor models
por: Tokhanbigli, Samaneh, et al.
Publicado: (2023)

High Prevalence of Antibiotic Resistance in Iranian Helicobacter pylori Isolates: Importance of Functional and Mutational Analysis of Resistance Genes and Virulence Genotyping
por: Farzi, Nastaran, et al.
Publicado: (2019)

The synergistic effect of Levilactobacillus brevis IBRC-M10790 and vitamin D3 on Helicobacter pylori-induced inflammation
por: Nabavi-Rad, Ali, et al.
Publicado: (2023)

Editorial: Helicobacter pylori infection and antibiotic resistance: clinical, translational and experimental studies
por: Yadegar, Abbas, et al.
Publicado: (2023)

Corrigendum to “Helicobacter pylori infection contributes to the expression of Alzheimer's disease-associated risk factors and neuroinflammation” [Heliyon 9(9) (September 2023) e19607]
por: Noori, Maryam, et al.
Publicado: (2023)

Genetic diversity of Helicobacter pylori type IV secretion system cagI and cagN genes and their association with clinical diseases
por: Azizimoghaddam, Yasaman, et al.
Publicado: (2023)

Effect of Statins on Helicobacter pylori Eradication Rate: A Systematic Review and Meta-Analysis
por: Rajabnia, Mohsen, et al.
Publicado: (2021)

Clarithromycin-Susceptible But Virulent Helicobacter pylori Strains Infecting Iranian Patients’ Stomachs
por: Khani, Shadiyeh, et al.
Publicado: (2019)

The prevalence of Helicobacter pylori is decreasing in Iranian patients
por: Ashtari, Sara, et al.
Publicado: (2015)

The Potential Use of Antibiotics Against Helicobacter pylori Infection: Biopharmaceutical Implications
por: Miri, Amir Hossein, et al.
Publicado: (2022)

The role of Helicobacter pylori and CagA in response to treatment in Iranian Gastroesophageal Reflux Diseases patients
por: Khoshbaten, Manouchehr, et al.
Publicado: (2013)

Genetic diversity and amino acid sequence polymorphism in Helicobacter pylori CagL hypervariable motif and its association with virulence markers and gastroduodenal diseases
por: Yadegar, Abbas, et al.
Publicado: (2019)

Highly clarithromycin-resistant Helicobacter pylori infection in asymptomatic children from a rural community of Cajamarca-Peru
por: Aguilar-Luis, Miguel Angel, et al.
Publicado: (2018)

The Effects of Helicobacter pylori-Derived Outer Membrane Vesicles on Hepatic Stellate Cell Activation and Liver Fibrosis In Vitro
por: Bolori, Shahin, et al.
Publicado: (2023)

Genotypic and Phenotypic Resistance to Clarithromycin in Helicobacter pylori Strains
por: Gong, Eun Jeong, et al.
Publicado: (2020)

Early genetic diagnosis of clarithromycin resistance in Helicobacter pylori
por: Li, Xiao-Hua, et al.
Publicado: (2021)

Molecular Characterization of Clarithromycin Resistance in Helicobacter pylori Strains
por: Örsten, Serra, et al.
Publicado: (2023)

Association of Helicobacter pylori with central serous chorioretinopathy in Iranian patients
por: Roshani, Mohammad, et al.
Publicado: (2014)

Antibiotic Susceptibility Profile of Helicobacter pylori Isolated from the Dyspepsia Patients in Tehran, Iran
por: Shokrzadeh, Leila, et al.
Publicado: (2011)

Intestinal microbiota changes pre- and post-fecal microbiota transplantation for treatment of recurrent Clostridioides difficile infection among Iranian patients with concurrent inflammatory bowel disease
por: Gholam-Mostafaei, Fahimeh Sadat, et al.
Publicado: (2023)

Evaluation of Clarithromycin Resistance Among Iranian Helicobacter pylori Isolates by E-Test and Real-Time Polymerase Chain Reaction Methods
por: Hakemi Vala, Mojdeh, et al.
Publicado: (2016)

Complete Genome Sequences of Helicobacter pylori Clarithromycin-Resistant Strains
por: Binh, Tran Thanh, et al.
Publicado: (2013)

A Novel Reduction Strategy of Clarithromycin Resistance in Helicobacter pylori
por: Tadjrobehkar, Omid, et al.
Publicado: (2014)

Mutant selection window of clarithromycin for clinical isolates of Helicobacter pylori
por: Feng, Zi-Han, et al.
Publicado: (2019)

Is Only Clarithromycin Susceptibility Important for the Successful Eradication of Helicobacter pylori?
por: Kim, Young Min, et al.
Publicado: (2020)

The Comparison of Levofloxacin- and Clarithromycin-Based Bismuth Quadruple Therapy Regimens in Helicobacter pylori Eradication
por: Arj, Abbas, et al.
Publicado: (2020)

Low rate of recurrence of Helicobacter Pylori infection in spite of high clarithromycin resistance in Pakistan
por: Yakoob, Javed, et al.
Publicado: (2013)

Eradication of Helicobacter pylori in Children by Triple Therapy Regimens of Amoxicillin, Omeprazole, and Clarithromycin or Azithromycin
por: Esmaeili-Dooki, Mohammad Reza, et al.
Publicado: (2015)

Low Dose Furazolidone for Eradication of Helicobacter pylori Instead of Clarithromycin: A Clinical Trial
por: Hajaghamohammadi, Aliakbar, et al.
Publicado: (2015)

Comparison of levofloxacin versus clarithromycin efficacy in the eradication of Helicobacter pylori infection
por: Haji-Aghamohammadi, Ali Akbar, et al.
Publicado: (2016)

Trends in Helicobacter pylori resistance to clarithromycin: from phenotypic to genomic approaches
por: Marques, Andreia T., et al.
Publicado: (2020)

Influence of low FODMAP-gluten free diet on gut microbiota alterations and symptom severity in Iranian patients with irritable bowel syndrome
por: Naseri, Kaveh, et al.
Publicado: (2021)

Sugar Codes Conjugated Alginate: An Innovative Platform to Make a Strategic Breakthrough in Simultaneous Prophylaxis of GERD and Helicobacter pylori Infection
por: Moayedi, Saeed, et al.
Publicado: (2020)

A Vonoprazan, Clarithromycin, and Metronidazole Regimen as Helicobacter pylori Eradication Therapy for Patients with Penicillin Allergy in Light of Clarithromycin Resistance
por: Adachi, Kazunori, et al.
Publicado: (2023)

Variability in Prevalence of Helicobacter pylori Strains Resistant to Clarithromycin and Levofloxacin in Southern Poland
por: Karczewska, Elżbieta, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_84sa13jn8vccrj0m33ng4co0gn